JBIO
Jade BiosciencesBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
JBIO vs peer average
69/100
JBIO vs. peer average (B vs. C)
Grade spread
A 1 · B 2 · C 3 · D 4 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
GOSS is the first available peer comparator.
Gossamer Bio is not a close mechanistic autoimmune antibody peer, but it is a useful small-cap biotech comp for timeline credibility, financing sentiment, and clinical-execution risk.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
JBIO
Jade Biosciences
GOSS
Gossamer Bio
Grade
B
A
Momentum
89
38
Value
41
41
Sentiment
52
100
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Constructive
Grade position vs GOSS
JBIO / GOSS
Grade Position
In line
JBIO vs. peer average (B vs. C)
69/100
Momentum
89
JBIOValue
41
JBIOSentiment
52
GOSSRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs JBIO
GOSS is the first peer returned for this comparison set.